Close
 

Figure 5: (a and b) Type I and Type III collagen immunonegativity in the control group. (c and d) Moderate level I and Type III collagen immunopositivity in the rivaroxaban group (arrowhead) (immunofluorescence-tendon)

Figure 5: (a and b) Type I and Type III collagen immunonegativity in the control group. (c and d) Moderate level I and Type III collagen immunopositivity in the rivaroxaban group (arrowhead) (immunofluorescence-tendon)